Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

O Kleveland, T Ueland, G Kunszt, M Bratlie… - International Journal of …, 2018 - Elsevier
Aim To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network
in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods 117 …
被引用次数：34 相关文章

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction.

O Kleveland, T Ueland, G Kunszt, M Bratlie… - … Journal of Cardiology, 2018 - europepmc.org
Aim To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network
in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods 117 …

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

O Kleveland, T Ueland, G Kunszt, M Bratlie… - 2018 - ntnuopen.ntnu.no
Aim To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network
in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods 117 …

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

O Kleveland, T Ueland… - International …, 2018 - internationaljournalofcardiology.com
Aim To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network
in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods 117 …

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

O Kleveland, T Ueland, G Kunszt, M Bratlie… - 2018 - munin.uit.no
Aim: To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine
network in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods …

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

O Kleveland, T Ueland, G Kunszt, M Bratlie… - 2018 - pubmed.ncbi.nlm.nih.gov
Aim To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network
in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods 117 …

Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction

O Kleveland, T Ueland… - International …, 2018 - internationaljournalofcardiology.com
Aim To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network
in patients with acute non-ST-elevation myocardial infarction (NSTEMI). Methods 117 …